North America Mice Model Market (2025-2030)
The North America Mice Model Market was valued at $640.7 Million in 2025 and projected to reach to $1011.9 Million by 2030, representing a compound annual growth rate of 9.6%. North America's mice model market is poised for sustained expansion through 2030, driven by escalating demand for personalized medicine research, increased funding for genetic disease studies, and the adoption of advanced transgenic and knockout mouse technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Mice Model Market Trends and Insights
- North America maintains a dominant position in the global mice model market, driven by substantial investments in biomedical research, pharmaceutical development, and academic institutions across the United States and Canada.
- The region's advanced infrastructure, regulatory frameworks, and concentration of leading research organizations support accelerating demand for preclinical and translational research models. North America's market expansion is underpinned by increasing adoption of genetically modified mice for disease modeling, drug discovery, and safety testing.
- North America benefits from strong government funding through agencies such as the NIH and NSERC, coupled with private sector investment in biotechnology and life sciences.
- The region's commitment to reducing animal testing through refined models and the rising complexity of disease research further propel market growth through 2030..
Key Market Statistics
- CAGR (2025-2030) 9.6% CAGR
- Market Size, 2025 ~USD 640.7 Million
- Forecast, 2030 ~USD 1011.9 Million
- Geography North America
North America Mice Model Market Overview
Market Leadership Position :
North America commands the largest share of the global mice model market, valued at $640.7 million in 2025, reflecting the region's dominance in preclinical research infrastructure and regulatory influence.
Strong Growth Trajectory :
The North American market is projected to grow at a 9.6% CAGR, expanding from $640.7 million in 2025 to $1,011.9 million by 2030, outpacing many global regions in absolute value growth.
US Market Dominance :
The United States represents $889.6 million of the North American market, driven by extensive NIH funding, pharmaceutical R&D investments, and world-leading academic research institutions conducting disease modeling studies.
Canadian Research Contribution :
Canada contributes $169.8 million to the regional market, supported by government research initiatives, university-based biomedical programs, and collaborative cross-border research partnerships with US institutions.
North America Mice Model Market Dynamics
- The region's robust pharmaceutical pipeline and emphasis on translational research continue to fuel market growth.
- US leadership in drug development and Canada's growing research capabilities ensure the region maintains its competitive advantage in preclinical testing and biomedical innovation. Key growth catalysts include rising investments in cancer research, neurological disorder studies, and immunology applications.
- The integration of AI-driven phenotyping and high-throughput screening technologies is enhancing the value proposition of mice models.
- Regulatory support from the FDA and Health Canada, combined with institutional collaborations and contract research organization expansion, will further accelerate market penetration across North America through 2030..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- North America's mice model market is valued at $640.7 million in 2025 and will reach $1,011.9 million by 2030, representing a 9.6% CAGR.
- North America leads the global market due to robust government funding, advanced research infrastructure, and high concentration of pharmaceutical and biotech companies.
- Genetically modified and disease-specific mouse models are driving North America's market growth as researchers demand more sophisticated preclinical tools.
- North America's regulatory environment and emphasis on the 3Rs principle (replacement, reduction, refinement) accelerate adoption of advanced mouse model technologies.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area, End User |
North America Mice Model Market Report Segmentation
6 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
By End User
- Academic & Research Institutes
- Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical Companies : Need detailed North American market data to optimize preclinical testing strategies, allocate R&D budgets across US and Canadian facilities, and accelerate drug development timelines using mice models.
- Contract Research Organizations (CROs) : Require market sizing and growth forecasts to expand service offerings, identify high-demand research areas in North America, and compete effectively for pharmaceutical and biotech client contracts.
- Academic & Research Institutions : Need regional market intelligence to secure funding, justify equipment investments, benchmark research capabilities against peer institutions, and attract collaborative partnerships across North America.
- Biotech & Life Sciences Companies : Seek North American market insights to validate business models, identify partnership opportunities with research institutions, and understand demand for specialized mice models in emerging therapeutic areas.
- Investors & Private Equity Firms : Require comprehensive regional market analysis to evaluate investment opportunities in mice model suppliers, CROs, and biotech companies operating in the high-growth North American preclinical research sector.
Key Companies in the North America Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 889.6 Million |
| Canada | USD 169.8 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Quantification : Obtain precise market sizing for North America ($640.7M in 2025) with country-level breakdown for US ($889.6M) and Canada ($169.8M), enabling accurate budget allocation and competitive positioning.
- Growth Forecasting & Planning : Access 5-year projections showing 9.6% CAGR growth to $1,011.9M by 2030, supporting strategic investment decisions and long-term business planning in the North American preclinical research sector.
- Competitive Intelligence : Benchmark your organization against regional market dynamics, identify emerging opportunities in US pharmaceutical R&D and Canadian academic research, and understand market consolidation trends specific to North America.
- Regulatory & Funding Insights : Understand North American regulatory landscape, NIH funding patterns, and government research initiatives driving mice model adoption across US and Canadian institutions for informed market entry strategies.
- Customer Segmentation Data : Target pharmaceutical companies, CROs, academic institutions, and biotech firms with region-specific insights on their mice model procurement patterns, research priorities, and investment capabilities in North America.
Frequently asked questions
What is the current size of the North America mice model market?
The North America mice model market is valued at $640.7 million in 2025 and is expected to grow to $1,011.9 million by 2030.
What is the projected growth rate for North America's mice model market?
North America's mice model market is projected to grow at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2030.
What factors are driving growth in North America's mice model market?
Key drivers include increased pharmaceutical R&D spending, government funding from agencies like the NIH, rising demand for genetically modified models, and regulatory emphasis on animal welfare and the 3Rs principle.
Which countries in North America dominate the mice model market?
The United States is the largest market in North America due to its concentration of pharmaceutical companies, research institutions, and government funding, followed by Canada.
How does North America's mice model market compare to other regions?
North America represents a significant portion of the global mice model market, driven by superior research infrastructure, regulatory frameworks, and investment levels compared to other regions.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
- Rest Of Latin America Mice Model Market
- Ksa Mice Model Market
- Other GCC Countries Mice Model Market
- UAE Mice Model Market
- GCC Countries Mice Model Market
- Rest Of The Middle East Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report